Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]

PARP inhibitors and their side effects in solid tumour therapy

Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA

PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )

Benefits and challenges of using PARP inhibitors to treat metastatic breast...

Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA

Benefits and challenges of using PARP inhibitors to treat metastatic breast cancer ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )

How genetic testing is guiding the use of PARP inhibitors

Suzanne Mahon - Saint Louis University, Missouri, USA

How genetic testing is guiding the use of PARP inhibitors ( Suzanne Mahon - Saint Louis University, Missouri, USA )

Pharmacology update from ONS 2019

Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA

Pharmacology update from ONS 2019 ( Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA )

Emerging uses of PARP inhibitors

Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA

Emerging uses of PARP inhibitors ( Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA )

Long-term safety of niraparib maintenance treatment in patients with recurrent...

Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA

Long-term safety of niraparib maintenance treatment in patients with recurrent ovarian cancer ( Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA )

Treating ovarian cancers with PARP inhibitors

Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA

Treating ovarian cancers with PARP inhibitors ( Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA )

Managing the side effects of CAR T-cell therapy

Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA

Managing the side effects of CAR T-cell therapy ( Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA )

Current treatment for brain tumours

Prof Mark Beresford - Royal United Hospital Bath, Bath, UK

Current treatment for brain tumours ( Prof Mark Beresford - Royal United Hospital Bath, Bath, UK )

The WIN symposium 2019

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA

The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )

An overview of the WIN consortium

Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical...

An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )

Making oncology global with the WIN consortium

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

More from ecancer